Ongoing, recruitingTherapeutic confirmatory (Phase III)Interventional

Pilot study RCT anti-NGF Adalimumab versus placebo in fasciotomy Dupuytren contracture

At a glance

Status

Ongoing, recruiting

Phase

Therapeutic confirmatory (Phase III)

Sponsor

UZ Leuven

Enrolment target

Start

05 Jul 2023

Obtain a minimum increase of 10° correction of the finger extension lack in the treatment group versus the placebo.

Age 18 Years to any · Sex: All

Always speak to your GP or specialist before deciding to take part in a study.